Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
about
The role of epigenetics in kidney malignanciesHigh-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq.The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.Epigenetic alteration and microRNA dysregulation in cancerChromatin modifications and genomic contexts linked to dynamic DNA methylation patterns across human cell types.DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies.Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma.Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and MetastasisRole of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.MiR-124 inhibits the migration and invasion of human hepatocellular carcinoma cells by suppressing integrin αV expression.GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response.The role of miR-24 as a race related genetic factor in prostate cancer.Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology.MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome.miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src.Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.The epigenetic landscape of renal cancer.Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.Methylation-mediated silencing of miR-124 facilitates chondrogenesis by targeting NFATc1 under hypoxic conditions.miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.A suite of DNA methylation markers that can detect most common human cancers.miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma.MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages.Epigenetics and MicroRNAs in Cancer.Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.Potential clinical applications of microRNAs as biomarkers for renal cell carcinoma
P2860
Q26801233-C2F8BBAC-8C46-4AB9-A9AE-8296FD382CDDQ34254966-CB8DDACE-0495-4AC1-9EAA-2F96AC99095CQ34334347-763BBFE8-8061-4A98-8267-017BAAF05E10Q34392645-206362DE-6686-4FFC-9FB4-3744FB204EC9Q35075589-9CE247E4-5A2C-4711-9117-0245F91A2DAEQ35122019-89C8CF21-F2D5-4810-9DDB-25203E0DF170Q35363913-7C70D834-F2FB-49B0-9CD4-3865FDE87827Q36107113-213BCE74-F4D5-4BEE-B058-3260AB377F88Q36150977-C17E488D-8A4D-47FE-9B56-951189C7BAEEQ36844904-FBA04000-A98F-44CE-A2D8-920BE07AC4E0Q37589647-0D2C706D-8EB2-4AE2-A97C-43B4F52AFB8CQ37685151-3830D301-3942-4EE6-BE0F-5198897CE781Q37703383-2F191983-B241-4E39-8B2C-DA596CEE4754Q37725482-479673E1-9D88-475A-A874-49F7386C82D4Q38152226-B8B7F6C7-2CA6-4C08-82F3-6C1B078BA453Q38356005-AE78E862-5F13-4774-B3B1-B495203412CDQ38664137-CB6A38C2-E593-4CEC-BE8D-6CD75A8A38C4Q38693627-E06921E7-D7C4-4B82-A40F-50573344DC17Q38819163-4E09892B-3D85-42AF-99DD-B2A66489423EQ38885469-CC19E3CE-DB02-469E-9B4C-56D37344C0E8Q38888825-BFB1B8E1-6B25-4D2C-A79A-7A2563C995E6Q39021700-8F02A5D8-70F8-4FCA-BBA7-12B616CA1CC3Q41035533-2180D147-5C22-47DA-9F78-FED82A524287Q42068034-972716B7-2E89-415A-A0B6-8B461B643B2EQ43869522-564CEA29-63AD-449C-9C8F-088BE1F03451Q47356569-AF4F9564-9D6E-4E21-B715-45FA927C417CQ48119486-7FAD04E6-E2A6-46D5-BC8C-AFA777973971Q50117508-B33EC4DC-7224-4CE9-8B15-0DE45B53087BQ51770872-A101D4AF-0F09-49E4-9D5A-FDAD48CB57D1Q54191554-6FF1C4F3-CB0A-470F-9A37-5AA752B2BA69Q58578839-30A5CBB5-E872-4E3A-8382-C7F23672C858
P2860
Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Hsa-mir-124-3 CpG island methy ...... lear cell renal cell carcinoma
@ast
Hsa-mir-124-3 CpG island methy ...... lear cell renal cell carcinoma
@en
type
label
Hsa-mir-124-3 CpG island methy ...... lear cell renal cell carcinoma
@ast
Hsa-mir-124-3 CpG island methy ...... lear cell renal cell carcinoma
@en
prefLabel
Hsa-mir-124-3 CpG island methy ...... lear cell renal cell carcinoma
@ast
Hsa-mir-124-3 CpG island methy ...... lear cell renal cell carcinoma
@en
P2093
P2860
P356
P1476
Hsa-mir-124-3 CpG island methy ...... lear cell renal cell carcinoma
@en
P2093
A S Merseburger
J Hennenlotter
M A Kuczyk
N Dubrowinskaja
P2860
P2888
P304
P356
10.1038/BJC.2012.537
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1038561271